SARS-CoV-2: Immunopeptidomics and Other Immunological Studies

Overview

Journal Vaccines (Basel)

Date 2022 Nov 24

PMID 36423070

Authors

Vivek P Chavda

Elrashdy M Redwan

Affiliations

Soon will be listed here.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has produced a significant continuing epidemic worldwide [...].

Citing Articles

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!.

Chavda V, Jogi G, Dave S, Patel B, Nalla L, Koradia K Vaccines (Basel). 2023; 11(3).

PMID: 36992091 PMC: 10052021. DOI: 10.3390/vaccines11030507.

References

Chong C, Coukos G, Bassani-Sternberg M . Identification of tumor antigens with immunopeptidomics. Nat Biotechnol. 2021; 40(2):175-188. DOI: 10.1038/s41587-021-01038-8. View

Kaur S, Gupta V . COVID-19 Vaccine: A comprehensive status report. Virus Res. 2020; 288:198114. PMC: 7423510. DOI: 10.1016/j.virusres.2020.198114. View

Chavda V, Ertas Y, Walhekar V, Modh D, Doshi A, Shah N . Advanced Computational Methodologies Used in the Discovery of New Natural Anticancer Compounds. Front Pharmacol. 2021; 12:702611. PMC: 8416109. DOI: 10.3389/fphar.2021.702611. View

Mayer R, Impens F . Immunopeptidomics for next-generation bacterial vaccine development. Trends Microbiol. 2021; 29(11):1034-1045. DOI: 10.1016/j.tim.2021.04.010. View

Obeid M, Suffiotti M, Pellaton C, Bouchaab H, Cairoli A, Salvade V . Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients. JAMA Oncol. 2022; 8(5):e220446. PMC: 8914885. DOI: 10.1001/jamaoncol.2022.0446. View

Vanpatten S, He M, Altiti A, F Cheng K, Ghanem M, Al-Abed Y . Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics. Future Med Chem. 2020; 12(18):1647-1656. PMC: 7364852. DOI: 10.4155/fmc-2020-0180. View

Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman L, Chen D, Gallagher K . Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell. 2021; 184(15):3962-3980.e17. PMC: 8173604. DOI: 10.1016/j.cell.2021.05.046. View

Caron E, Kowalewski D, Koh C, Sturm T, Schuster H, Aebersold R . Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry. Mol Cell Proteomics. 2015; 14(12):3105-17. PMC: 4762616. DOI: 10.1074/mcp.O115.052431. View

Knierman M, Lannan M, Spindler L, McMillian C, Konrad R, Siegel R . The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein. Cell Rep. 2020; 33(9):108454. PMC: 7664343. DOI: 10.1016/j.celrep.2020.108454. View

10.

Shalash A, Azuar A, Madge H, Modhiran N, Amarilla A, Liang B . Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems. Pharmaceutics. 2022; 14(4). PMC: 9024957. DOI: 10.3390/pharmaceutics14040856. View

11.

Chavda V, Pandya R, Apostolopoulos V . DNA vaccines for SARS-CoV-2: toward third-generation vaccination era. Expert Rev Vaccines. 2021; 20(12):1549-1560. PMC: 8567274. DOI: 10.1080/14760584.2021.1987223. View

12.

Panagioti E, Klenerman P, Lee L, van der Burg S, Arens R . Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections. Front Immunol. 2018; 9:276. PMC: 5820320. DOI: 10.3389/fimmu.2018.00276. View

13.

Feola S, Chiaro J, Martins B, Russo S, Fusciello M, Ylosmaki E . A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines. Elife. 2022; 11. PMC: 8989416. DOI: 10.7554/eLife.71156. View

14.

Bettencourt P, Muller J, Nicastri A, Cantillon D, Madhavan M, Charles P . Identification of antigens presented by MHC for vaccines against tuberculosis. NPJ Vaccines. 2020; 5(1):2. PMC: 6941960. DOI: 10.1038/s41541-019-0148-y. View

15.

Gentile I, Scotto R, Schiano Moriello N, Pinchera B, Villari R, Trucillo E . Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study. Vaccines (Basel). 2022; 10(10). PMC: 9607194. DOI: 10.3390/vaccines10101731. View

16.

Xin L, Qiao R, Chen X, Tran H, Pan S, Rabinoviz S . A streamlined platform for analyzing tera-scale DDA and DIA mass spectrometry data enables highly sensitive immunopeptidomics. Nat Commun. 2022; 13(1):3108. PMC: 9174175. DOI: 10.1038/s41467-022-30867-7. View

17.

Li C, Revote J, Ramarathinam S, Chung S, Croft N, Scull K . Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies. Proteomics. 2021; 21(17-18):e2100036. PMC: 8250278. DOI: 10.1002/pmic.202100036. View

18.

Wahongan I, Suoth E, Fatimawali , Alhumaid S, Albayat H, Aljeldah M . Designing an Epitope-Based Peptide Vaccine Derived from RNA-Dependent RNA Polymerase (RdRp) against Dengue Virus Serotype 2. Vaccines (Basel). 2022; 10(10). PMC: 9611443. DOI: 10.3390/vaccines10101734. View

19.

Kaabinejadian S, Barra C, Alvarez B, Yari H, Hildebrand W, Nielsen M . Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome. Front Immunol. 2022; 13:835454. PMC: 8826445. DOI: 10.3389/fimmu.2022.835454. View

20.

Dilokthornsakul W, Kosiyaporn R, Wuttipongwaragon R, Dilokthornsakul P . Potential effects of propolis and honey in COVID-19 prevention and treatment: A systematic review of in silico and clinical studies. J Integr Med. 2022; 20(2):114-125. PMC: 8801981. DOI: 10.1016/j.joim.2022.01.008. View